,0
zip,01923
sector,Healthcare
fullTimeEmployees,2003
longBusinessSummary,"Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts."
city,Danvers
phone,978 646 1400
state,MA
country,United States
companyOfficers,[]
website,https://www.abiomed.com
maxAge,1
address1,22 Cherry Hill Drive
fax,978 777 8411
industry,Medical Devices
ebitdaMargins,0.27519
profitMargins,0.13229999
grossMargins,0.81763
operatingCashflow,285390016
revenueGrowth,0.119
operatingMargins,0.24797001
ebitda,283932992
targetLowPrice,260
recommendationKey,buy
grossProfits,843595000
freeCashflow,200419504
targetMedianPrice,357.5
currentPrice,266.34
earningsGrowth,0.056
currentRatio,7.053
returnOnAssets,0.100959994
numberOfAnalystOpinions,6
targetMeanPrice,347.5
debtToEquity,0.665
returnOnEquity,0.096370004
targetHighPrice,425
totalCash,758606976
totalDebt,9996000
totalRevenue,1031753024
totalCashPerShare,16.649
financialCurrency,USD
revenuePerShare,22.703
quickRatio,6.133
recommendationMean,2.5
exchange,NMS
shortName,"ABIOMED, Inc."
longName,"Abiomed, Inc."
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,ABMD
messageBoardId,finmb_247589
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,11.036
beta3Year,
enterpriseToEbitda,40.104
52WeekChange,-0.047765434
morningStarRiskRating,
forwardEps,5.65
revenueQuarterlyGrowth,
sharesOutstanding,45563900
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,33.007
sharesShort,1530570
sharesPercentSharesOut,0.0336
fundFamily,
lastFiscalYearEnd,1648684800
heldPercentInstitutions,0.94574
netIncomeToCommon,136504992
trailingEps,2.98
lastDividendValue,
SandP52WeekChange,-0.010423481
priceToBook,8.069198
heldPercentInsiders,0.01995
nextFiscalYearEnd,1711843200
yield,
mostRecentQuarter,1648684800
shortRatio,4.53
sharesShortPreviousMonthDate,1649894400
floatShares,44690476
beta,1.345089
enterpriseValue,11386888192
priceHint,2
threeYearAverageReturn,
lastSplitDate,970444800
lastSplitFactor,2:1
legalType,
lastDividendDate,
morningStarOverallRating,
earningsQuarterlyGrowth,0.061
priceToSalesTrailing12Months,11.76201
dateShortInterest,1652400000
pegRatio,15.05
ytdReturn,
forwardPE,47.13982
lastCapGain,
shortPercentOfFloat,0.038399998
sharesShortPriorMonth,1275595
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,260.97
regularMarketOpen,263.4
twoHundredDayAverage,319.34964
trailingAnnualDividendYield,0
payoutRatio,0
volume24Hr,
regularMarketDayHigh,268.84
navPrice,
averageDailyVolume10Day,371210
regularMarketPreviousClose,260.97
fiftyDayAverage,288.6022
trailingAnnualDividendRate,0
open,263.4
toCurrency,
averageVolume10days,371210
expireDate,
algorithm,
dividendRate,
exDividendDate,
circulatingSupply,
startDate,
regularMarketDayLow,261.045
currency,USD
trailingPE,89.37584
regularMarketVolume,273177
lastMarket,
maxSupply,
openInterest,
marketCap,12135488512
volumeAllCurrencies,
strikePrice,
averageVolume,298488
dayLow,261.045
ask,350
askSize,800
volume,273177
fiftyTwoWeekHigh,379.3
fromCurrency,
fiveYearAvgDividendYield,
fiftyTwoWeekLow,226.46
bid,106.14
tradeable,False
dividendYield,
bidSize,1200
dayHigh,268.84
regularMarketPrice,266.34
preMarketPrice,
logo_url,https://logo.clearbit.com/abiomed.com
